Recombinant expression vector applicable to rapid screening for recombinant strain and application
US-12037632-B2 · Jul 16, 2024 · US
Gene for biosynthesis of core structure of ophiobolin
US2018009855A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2018009855-A1 |
| Application number | US-201715712172-A |
| Country | US |
| Kind code | A1 |
| Filing date | Sep 22, 2017 |
| Priority date | Mar 24, 2015 |
| Publication date | Jan 11, 2018 |
| Grant date | — |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
A gene for biosynthesis of core structure of ophiobolin, the gene being the AuOS gene of Aspergillus sp. 094102, deposited with the accession number CCTCC No: M208153, the gene sequence thereof being shown as SEQ ID NO. 1. Also provided is a method of preparation of ophiobolin using the gene.
First claim
Opening claim text (preview).
The invention claimed is: 1 . A gene for biosynthesis of ophiobolin, wherein the gene is AuOS gene of Aspergillus sp. 094102, deposited with the accession number CCTCC No: M208153, and a gene sequence thereof is shown in SEQ ID NO. 1. 2 . The gene of claim 1 , wherein the AuOS gene has a cDNA sequence shown in SEQ ID NO. 2. 3 . An AuOS protein being encoded by the gene of claim 1 , the protein having an amino acid sequence shown in SEQ ID NO. 3. 4 . A method of preparation of ophiobolin, the method comprising applying a gene comprising a sequence shown in SEQ ID NO. 1 or SEQ ID NO. 2, or an AuOS protein having an amino acid sequence shown in SEQ ID NO. 3.
Assignees
Inventors
Classifications
- C07K14/38Primary
from Aspergillus · CPC title
containing a hydroxy group · CPC title
transferring alkyl or aryl groups other than methyl groups (2.5) · CPC title
Transferases (2.) (ribonucleases C12N9/22) · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US2018009855A1 cover?
- A gene for biosynthesis of core structure of ophiobolin, the gene being the AuOS gene of Aspergillus sp. 094102, deposited with the accession number CCTCC No: M208153, the gene sequence thereof being shown as SEQ ID NO. 1. Also provided is a method of preparation of ophiobolin using the gene.
- Who is the assignee on this patent?
- Univ Wuhan
- What technology area does this patent fall under?
- Primary CPC classification C07K14/38. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Thu Jan 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).